Mahdi Fasihi-Ramandi, Samira Dodangeh, Shahabeddin Sarvi, Ahmad Daryani, Abolghasem Ajami, Tooran Nayeri, Hossein Asgarian-Omran, Zahra Hosseininejad
Journal: Infectious disorders drug targets 2025;25(3):e18715265332103
PMID: 39350555
BACKGROUND
Toxoplasmosis is a cosmopolitan infectious disease in warmblooded mammals that poses a serious worldwide threat due to the lack of effective medications and vaccines.
AIMS
The purpose of this study was to design a multi-epitope vaccine using several bioinformatics approaches against the antigens of .
METHODS
Three proteins of , including ROP18, MIC4, and SAG1 were analyzed to predict the most dominant B- and T-cell epitopes. Finally, we designed a chimeric immunogen RMS (ROP18, MIC4, and SAG1) using some domains of ROP18 (N377-E546), MIC4 (D302-G471), and SAG1 (T130-L299) linked by rigid linker A (EAAAK) A. Physicochemical properties, secondary and tertiary structure, antigenicity, and allergenicity of RMS were predicted utilizing immunoinformatic tools and servers.
RESULTS
RMS protein had 545 amino acids with a molecular weight (MW) of 58,833.46 Da and a theoretical isoelectric point (IP) of 6.47. The secondary structure of RMS protein contained 21.28% alpha-helix, 24.59% extended strand, and 54.13% random coil. In addition, evaluation of antigenicity and allergenicity showed the protein to be an immunogen and nonallergen. The results of the Ramachandran plot indicated that 76.4%, 12.9%, and 10.7% of amino acid residues were incorporated in the favored, allowed, and outlier regions respectively. ΔG of the best-predicted mRNA secondary structure was -593.80 kcal/mol which indicates a stable loop is not formed at the 5' end.
CONCLUSION
Finally, the accuracy and precision of the analysis must be confirmed by successful heterologous expression and experimental studies.
Copyright© Bentham Science Publishers; For any queries, please email at [email protected].
Medical:
Miscellaneous:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.